Federation des caisses Desjardins du Quebec’s GSK GSK Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.39M	Sell	45,513 -10,484	-19%	-$554K	0.01%	755
2026 Q1	$3.09M	Sell	55,997 -1,016	-2%	-$55.1K	0.01%	607
2025 Q4	$2.8M	Sell	57,013 -5,854	-9%	-$273K	0.01%	617
2025 Q3	$2.71M	Buy	62,867 +22,425	+55%	+$876K	0.01%	623
2025 Q2	$1.55M	Sell	40,442 -2,416	-6%	-$92.3K	0.01%	728
2025 Q1	$1.66M	Sell	42,858 -1,323	-3%	-$48.4K	0.01%	673
2024 Q4	$1.49M	Buy	44,181 +46	+0.1%	+$1.66K	0.01%	686
2024 Q3	$1.8M	Sell	44,135 -23	-0.1%	-$941	0.01%	612
2024 Q2	$1.7M	Sell	44,158 -1,077	-2%	-$45.3K	0.01%	595
2024 Q1	$1.94M	Buy	45,235 +1,353	+3%	+$55.8K	0.01%	535
2023 Q4	$1.63M	Sell	43,882 -28,925	-40%	-$1.04M	0.02%	489
2023 Q3	$2.64M	Buy	72,807 +1,212	+2%	+$43K	0.03%	366
2023 Q2	$2.55M	Sell	71,595 -751	-1%	-$26.9K	0.03%	386
2023 Q1	$2.57M	Buy	72,346 +2,209	+3%	+$77.3K	0.03%	348
2022 Q4	$2.46M	Sell	70,137 -8,852	-11%	-$295K	0.03%	334
2022 Q3	$2.32M	Sell	78,989 -201,599	-72%	-$7.64M	0.03%	357
2022 Q2	$15.3M	Sell	280,588 -4,941	-2%	-$273K	0.17%	125
2022 Q1	$15.5M	Buy	285,529 +5,335	+2%	+$290K	0.15%	134
2021 Q4	$15.4M	Buy	280,194 +4,240	+2%	+$221K	0.15%	130
2021 Q3	$13.2M	Buy	275,954 +8,583	+3%	+$431K	0.14%	132
2021 Q2	$13.3M	Buy	267,371 +19,524	+8%	+$938K	0.13%	131
2021 Q1	$11.1M	Buy	247,847 +11,071	+5%	+$503K	0.12%	147
2020 Q4	$10.9M	Buy	236,776 +9,738	+4%	+$447K	0.13%	147
2020 Q3	$10.7M	Buy	227,038 +8,775	+4%	+$440K	0.15%	135
2020 Q2	$11.1M	Buy	218,263 +6,870	+3%	+$352K	0.17%	118
2020 Q1	$10M	Sell	211,393 -578	-0.3%	-$30.8K	0.17%	106
2019 Q4	$12.5M	Buy	211,971 +873	+0.4%	+$48.6K	0.17%	99
2019 Q3	$11.3M	Sell	211,098 -872	-0.4%	-$44.9K	0.16%	106
2019 Q2	$10.6M	Buy	211,970 +488	+0.2%	+$24.5K	0.16%	114
2019 Q1	$11M	Sell	211,482 -3,056	-1%	-$153K	0.17%	110
2018 Q4	$10.2M	Sell	214,538 -25,564	-11%	-$1.26M	0.17%	109
2018 Q3	$12.1M	Sell	240,102 -2,599	-1%	-$132K	0.18%	103
2018 Q2	$12.2M	Sell	242,701 -2,046	-0.8%	-$103K	0.18%	99
2018 Q1	$12M	Sell	244,747 -4,959	-2%	-$231K	0.19%	98
2017 Q4	$11.1M	Sell	249,706 -7,162	-3%	-$331K	0.17%	116
2017 Q3	$13M	Buy	256,868 +8,969	+4%	+$455K	0.21%	100
2017 Q2	$13.4M	Buy	247,899 +6,002	+2%	+$320K	0.22%	95
2017 Q1	$12.7M	Buy	+241,897	New	+$12.3M	0.24%	83

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's GSK Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec reduced its GSK (GSK) stake by 19% in Q2 2026, selling an estimated $554K and leaving 45,513 shares worth $2.39M. The position accounts for 0.01% of the portfolio, ranked #755.

Federation des caisses Desjardins du Quebec first reported a position in GSK in Q1 2017 and has held it in 38 quarters since. The position peaked at $15.5M in Q1 2022. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Federation des caisses Desjardins du Quebec held 45,513 shares of GSK worth $2.39M as of Q2 2026.
Federation des caisses Desjardins du Quebec sold 10,484 GSK shares in Q2 2026, an estimated $554K.
GSK made up 0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #755 holding.
Federation des caisses Desjardins du Quebec first reported a position in GSK in Q1 2017 and has held it in 38 quarters since.
Federation des caisses Desjardins du Quebec's GSK position peaked at $15.5M in Q1 2022.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.